“…These drugs, which benefit only between a third to two-thirds of recipients (in terms of relapse prevention or symptom reduction), have serious health risks (Ross & Read, 2004;Mosher et al, 2004), including increased mortality risk (Weinmann et al, 2009), for all recipients, leading to high levels of 'non-compliance'. Meanwhile a range of psychological interventions that address the psycho-social causes and the maladaptive mechanisms identified above, have been found to be effective, at least for some patients, and are free from health risks for all (Gleeson et al, 2008;Read et al, 2004c;Alanen, 2009;Morrison, 2009). Meanwhile a range of psychological interventions that address the psycho-social causes and the maladaptive mechanisms identified above, have been found to be effective, at least for some patients, and are free from health risks for all (Gleeson et al, 2008;Read et al, 2004c;Alanen, 2009;Morrison, 2009).…”